What is Adamax?
Adamax is a synthetic peptide that is an analog of Semax (a derivative of the ACTH₄₋₁₀ fragment with the sequence Met-Glu-His-Phe-Pro-Gly-Pro), most commonly described as Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly-NH₂ or a variant with an additional adamantyl modification. Terminal modifications (N-terminal acetylation and C-terminal changes) increase resistance to enzymatic degradation and influence the physicochemical properties of the molecule.
This compound was developed as a research model as part of work on stable analogues of short ACTH-derived peptides. Due to the introduced structural modifications and specific lipophilicity, Adamax constitutes a useful tool for research on peptide signaling in experimental systems.
In preclinical research, it is used to analyze mechanisms related to the modulation of neurotrophic factor expression (including BDNF and NGF), the activation of TrkB-dependent and melanocortin receptor (MC3/MC4) pathways, as well as to evaluate the reorganization of cellular processes in in vitro and in vivo models. Attention has been drawn to its interactions with signaling pathways and its indirect effect on processes induced by oxidative stress under experimental conditions.
Due to its precisely defined chemical structure and the reproducibility of observed biological effects in preclinical models, Adamax is used as a research tool in molecular biology, cellular neurobiology, and experimental pharmacology. In scientific literature, it is sometimes utilized as a reference peptide for evaluating neurotrophic signaling processes and for validating analytical methods used in the study of short bioactive peptides.
Disclaimer
Products in this category are not medicines, food products, or dietary supplements. The products are classified as chemical reagents/reference materials authorized for marketing within the European Union and may be used exclusively for laboratory scientific research.